{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T14:28:19Z","timestamp":1655476099597},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T00:00:00Z","timestamp":1457568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0151093","type":"journal-article","created":{"date-parts":[[2016,3,10]],"date-time":"2016-03-10T18:57:52Z","timestamp":1457636272000},"page":"e0151093","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Breastfeeding and Immunohistochemical Expression of ki-67, p53 and BCL2 in Infiltrating Lobular Breast Carcinoma"],"prefix":"10.1371","volume":"11","author":[{"given":"Angel","family":"Gonzalez-Sistal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Baltasar-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Primitiva","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Ignacio","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Ruibal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,3,10]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.breast.2010.08.007","article-title":"Breastfeeding and prognostic markers in breast cancer","volume":"20","author":"M L\u00f6\u00f6f-Johanson","year":"2011","journal-title":"Breast"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.7748\/ns.24.18.35.s50","article-title":"Breast cancer risk in women: the protective role of pregnancy","volume":"24","author":"V Costarelli","year":"2010","journal-title":"Nurs Stand"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1158\/1055-9965.EPI-07-2824","article-title":"Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study","volume":"17","author":"SJ Lord","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/sj.bjc.6604275","article-title":"Parity and breastfeeding are protective against breast cancer in Nigerian women","volume":"98","author":"D Huo","year":"2008","journal-title":"Br J Cancer"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.breast.2012.08.005","article-title":"Association between common risk factors and molecular subtypes in breast cancer patients","volume":"22","author":"FP Turkoz","year":"2013","journal-title":"Breast"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejca.2007.10.009","article-title":"Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes","volume":"44","author":"EA Rakha","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/cncr.23786","article-title":"Reproductive and hormonal risk factors for postmenopausal luminal, HER-2 overexpressing, and triple\u2014negative breast cancer","volume":"113","author":"AI Phipps","year":"2008","journal-title":"Cancer"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1089\/jwh.2008.0917","article-title":"A systematic review of the association between breastfeeding and breast cancer","volume":"17","author":"L Yang","year":"2008","journal-title":"J Womens Health (Larchmt)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-0-387-74039-3_1","article-title":"Overview of resistance to systemic therapy in patients with breast cancer","volume":"608","author":"AM Gonzalez-Angulo","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(10)60636-8","article-title":"Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study","volume":"375","author":"RT Travis","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mds238","article-title":"A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative","volume":"24","author":"O Brouckaert","year":"2013","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","article-title":"Ki67 in breast cancer: prognostic and predictive potential","volume":"11","author":"R Yerushalmi","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10911-009-9119-7","article-title":"Pregnancy and breast cancer: when they collide","volume":"14","author":"TR Lyons","year":"2009","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/1471-2407-10-226","article-title":"Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway","volume":"10","author":"G Albrektsen","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2353\/ajpath.2009.080653","article-title":"Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation","volume":"174","author":"F Sotgia","year":"2009","journal-title":"Am J Pathol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2353\/ajpath.2009.080658","article-title":"Caveolin-1 -\/- null mammary stromal fibroblast share characteristics with human breast cancer-associated fibroblasts","volume":"174","author":"F Sotgia","year":"2009","journal-title":"Am J Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.breast.2009.02.009","article-title":"Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients","volume":"18","author":"FG Wiesner","year":"2009","journal-title":"Breast"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-010-1028-3","article-title":"MIB1\/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups","volume":"127","author":"MA Aleskandarany","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.clbc.2013.12.013","article-title":"Prognostic significance of the Ki67 scoring categories in breast cancer subgroups","volume":"14","author":"N Niikura","year":"2014","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/bjc.2015.239","article-title":"Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma","volume":"113","author":"L Rossi","year":"2015","journal-title":"Br J Cancer"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/bjc.2014.338","article-title":"Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma","volume":"111","author":"CC Engels","year":"2014","journal-title":"Br J Cancer"},{"issue":"1","key":"ref22","first-page":"269","article-title":"Association Between Tumor Size and Immunohistochemical Expression of Ki-67, p53 and BCL2 in a Node-negative Breast Cancer Population Selected from a Breast Cancer Screening Program","volume":"34","author":"A Gonz\u00e1lez-Sistal","year":"2014","journal-title":"Anticancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0151093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:05:57Z","timestamp":1588975557000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0151093"}},"subtitle":[],"editor":[{"given":"Anthony W.I.","family":"Lo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,10]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0151093","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,10]]}}}